PHESGO 1200MG/600MG INJECTION

PHESGO 1200MG/600MG INJECTION can affect fertility in some patients, although the extent of this effect is not well-understood. Women who wish to preserve their fertility should discuss their options with their healthcare provider before starting treatment with these drugs.

Yes, PHESGO 1200MG/600MG INJECTION are often combined with chemotherapy to treat HER2-positive breast cancer. This combination therapy effectively reduces the risk of recurrence and improves overall survival in patients with HER2-positive breast cancer.

If you have active tuberculosis (TB) infection, PHESGO 1200MG/600MG INJECTION should not be used until the TB infection has been treated and is under control. These drugs can suppress the immune system, worsening TB or other infections.

Yes, PHESGO 1200MG/600MG INJECTION can cause skin reactions, including rash, dry skin, and itching. In some cases, these skin reactions can be severe and require treatment. Patients should promptly report any new or worsening skin symptoms to their healthcare provider.

Yes, PHESGO 1200MG/600MG INJECTION can affect blood counts and may increase the risk of anemia, thrombocytopenia, and neutropenia. These blood disorders can cause symptoms such as fatigue, weakness, and an increased risk of infections or bleeding. Patients receiving this medication should check their blood counts regularly.

Yes, PHESGO 1200MG/600MG INJECTION can be used in older adults. However, older adults may be at increased risk of side effects like heart-related complications or infections. Healthcare providers may need to adjust the dose or monitor more closely for potential side effects in older patients.

Yes, PHESGO 1200MG/600MG INJECTION can be used in men with HER2-positive breast cancer. Breast cancer is rare in men, accounting for less than 1% of all breast cancer cases. However, HER2-positive breast cancer is more common in men than in women with breast cancer.

Yes, PHESGO 1200MG/600MG INJECTION can interact with other medications. It is important to inform your doctor about all medicines, supplements, and herbal products you are taking to avoid potential interactions.

When prescribed PHESGO 1200MG/600MG INJECTION, carefully read the warnings and precautions. Monitor for allergic reactions like rash, itching, or swelling and seek immediate medical help if they occur. Use with caution if you have severe kidney problems. Inform your doctor if you have heart issues, have received radiotherapy, or have allergic conditions.

Use effective birth control during treatment and for at least seven months after the last dose. Maintain a healthy and balanced diet for overall health and well-being.

PHESGO 1200MG/600MG INJECTION contains PERTUZUMAB and TRASTUZUMAB as active ingredients.

PHESGO 1200MG/600MG INJECTION is used to treat HER2-positive breast cancer.

Yes, PHESGO 1200MG/600MG INJECTION is an anti-cancer medicine used specifically for HER2-positive breast cancer.